President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Ozempic, along with its sister drug Wegovy, belongs to a new class of therapeutic known as GLP-1 receptor agonists. Originally developed for diabetes management, these medications have found a ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...